Cell & Gene Therapy Regulatory Affairs Summit

𝗧𝗵𝗲 𝗨𝗹𝘁𝗶𝗺𝗮𝘁𝗲 𝗖𝗵𝗮𝗻𝗰𝗲 𝘁𝗼 𝗧𝗮𝗰𝗸𝗹𝗲 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗦𝗽𝗮𝗰𝗲! With over 5,000 cell and gene therapies in pre-clinical and clinical development worldwide, regulatory clarity is crucial for developers striving for efficient and seamless approvals in their first regulatory submissions. Leading innovators are pioneering new approaches, like in vivo gene editing, rapidly pushing products from the clinic to commercialization. This rapidly evolving field is now on a mission to learn from case studies and glean insights from the forefront to optimize regulatory processes from pre-IND to approval. Introducing the inaugural 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 in Washington D.C. This event will unite biopharma experts across 𝗻𝗼𝗻-𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹, 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹, and 𝗖𝗠𝗖 regulatory domains in the cell and gene therapy sector. This is a uniquely positioned platform for the community to crystallize regulations, learn from the experiences of trailblazers, and engage in conversations to unravel regulatory bottlenecks. 𝗙𝘂𝗹𝗹 𝗔𝗴𝗲𝗻𝗱𝗮 - https://ter.li/3ir9uh Don’t miss this opportunity to gain exclusive insights from industry giants such as 𝗢𝗿𝗰𝗵𝗮𝗿𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, 𝗔𝘀𝘁𝗿𝗮𝗭𝗲𝗻𝗲𝗰𝗮, 𝗖𝗲𝗻𝘁𝘂𝗿𝘆 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯, 𝗖𝘆𝘁𝗼𝗜𝗺𝗺𝘂𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, 𝗣𝗿𝗶𝗺𝗲 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲, 𝗩𝗲𝗿𝘃𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀, and more, as they work collaboratively to tackle the regulatory challenges facing the cell and gene therapy community. 𝗕𝗼𝗼𝗸 𝗢𝗻𝗹𝗶𝗻𝗲 (𝗴𝗿𝗼𝘂𝗽 𝗱𝗶𝘀𝗰𝗼𝘂𝗻𝘁𝘀 𝗼𝗳 𝘂𝗽 𝘁𝗼 𝟮𝟬% 𝗼𝗳𝗳 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲) - https://ter.li/vp9h4t

Event Links

Website: https://go.evvnt.com/2504368-0

Tickets: https://go.evvnt.com/2504368-1

Brochure: https://go.evvnt.com/2504368-3

Read More

View Less